tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cyclacel Pharmaceuticals regains compliance with Nasdaq

Cyclacel Pharmaceuticals (CYCC) announced that it has received a letter from Nasdaq, informing the company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2).

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1